McCormick Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

McCormick & Company (MKC) is scheduled to report Q2 earnings on June 26, with analysts projecting a year-over-year EPS decline to $0.65 despite an anticipated revenue increase to $1.66 billion. The company recently declared a $0.45 quarterly dividend, while its shares closed down 1.4% at $73.64 on Wednesday. Analyst sentiment is mixed ahead of the release, with several firms like TD Cowen, Jefferies, and Argus Research recently upgrading the stock to "Buy," though JP Morgan maintains an "Underweight" rating, indicating varied outlooks despite upward price target revisions.

Analysis

McCormick & Company (MKC) faces a critical inflection point with its upcoming Q2 earnings release, as consensus estimates present a conflicting picture. While revenue is anticipated to grow a modest 1.2% year-over-year to $1.66 billion, earnings per share are projected to decline by 5.8% to $0.65 from $0.69 in the prior-year period, signaling potential margin compression. Analyst sentiment reflects this uncertainty, creating a distinct bull-bear divide. On one hand, several firms including TD Cowen and Jefferies have recently upgraded the stock to "Buy" with price targets in the $88-$91 range, suggesting significant upside from its recent closing price of $73.64. On the other hand, JP Morgan maintains an "Underweight" rating, albeit with a slightly increased price target of $69, indicating persistent skepticism. The company's declaration of a stable $0.45 quarterly dividend provides a baseline for shareholder returns, but the recent 1.4% share price decline suggests investor apprehension ahead of the report.

Key Decisions for Investors

• Investors should critically evaluate the upcoming earnings report for insights into margin performance, as the divergence between expected revenue growth and the projected EPS decline is a significant red flag.
• Given the recent upgrades to 'Buy' from several analysts with price targets well above the current share price, the pre-earnings valuation may present an opportunity for those betting on a positive surprise or strong forward guidance.
• Considering the conflicting analyst ratings, particularly the persistent 'Underweight' from a high-accuracy JP Morgan analyst, a prudent strategy would be to await the earnings results and management's commentary before initiating or expanding a position.